| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $113.8M | +1.1% |
| SG&A Expense | $30.0M | -9.5% |
| Operating Income | -$143.7M | +1.3% |
| Pre-tax Income | $134.2M | -5.4% |
| Income Tax | $0 | — |
| Net Income | -$134.2M | +5.4% |
| EPS (Basic) | -$1.77 | +31.9% |
| EPS (Diluted) | -$1.77 | +31.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $225.1M | +60.8% |
| Current Assets | $263.9M | +6.4% |
| Total Assets | $297.7M | +4.4% |
| Current Liabilities | $17.9M | -19.8% |
| Total Liabilities | $47.1M | -12.6% |
| Stockholders' Equity | $250.6M | +8.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$121.1M | -4.2% |
| Capital Expenditures | $193K | -97.0% |
| Investing Cash Flow | $70.7M | +21.0% |
| Financing Cash Flow | $135.5M | +10.3% |
| Free Cash Flow | -$121.3M | +1.2% |